BioLight Life Sciences Ltd. (TLV:BOLT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
234.30
+16.40 (7.53%)
Apr 3, 2026, 1:44 PM IDT
Market Cap21.20M -9.7%
Revenue (ttm)n/a
Net Income-11.73M
EPS-1.98
Shares Out9.05M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume64,094
Average Volume22,700
Open210.00
Previous Close217.90
Day's Range209.20 - 255.00
52-Week Range209.60 - 661.90
Beta0.37
RSI27.46
Earnings DateApr 6, 2026

About BioLight Life Sciences

BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions. The company’s ophthalmic product offering and pipeline of product candidates include DiagnosTear’s TeaRx technology, a diagnostic platform for diagnosis of disease in the frontal areas of the eye through examination of a number of substances in the composition of teardrops; ViSci, an Eye D technology that treats glaucoma by the insertion of a sub conjunctival impl... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 4
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BOLT
Full Company Profile

Financial Performance

Financial Statements